RecruitingNot ApplicableNCT06150261

Effects of an Omega-3 Fatty Acid-based Supplement on Healthy Ageing

Tolerability and Effects of a New Omega-3 Fatty Acid-based Supplement on Clinical and Biological Markers of Healthy Ageing


Sponsor

Helse Stavanger HF

Enrollment

100 participants

Start Date

Dec 8, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomised, double-blind placebo controlled trial is to explore tolerability and the effects of a new omega-3 fatty acid-based supplement on biological and clinical aspects relevant for healthy ageing. Participants will be asked to take a supplement or a placebo for 6 months, and to attend the clinic a total of 3 times and to perform or submit the following: * Physical examination * Muscle function tests * Cognitive testing * Questionnaire completion * Biological samples, including blood, saliva and faeces. Researchers will compare the results from the group taking the supplement to the results of the group taking a placebo to see if the supplement has an effect on biological and clinical aspects associated with healthy ageing.


Eligibility

Min Age: 55 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying AvailOm and Placebo for people with ageing well and healthy aging. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTAvailOm

5 capsules taken once daily with main meal

DIETARY_SUPPLEMENTPlacebo

5 capsules taken once daily with main meal


Locations(1)

Stavanger Universitetssjukehus

Stavanger, Norway

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06150261


Related Trials